This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909–1918.
Vaudo G, Schillaci G, Evangelista F, Pasqualini L, Verdecchia P, Mannarino E . Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. Am J Hypertens 2000; 13: 324–331.
Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C et al. Prevalence and correlates of left arterial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome. The Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875–882.
de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH . Effect of growth on variability of left ventricular mass; assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056–1062.
2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.
Cuspidi C, Meani S, Fusi V, Valerio C, Sala C, Zanchetti A . Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage. J Hypertens 2006; 24: 573–580.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 1–18.
Schmieder RE . The role of non-haemodynamic factors of the genesis of LVH. Nephrol Dial Transplant 2005; 20: 2610–2612.
Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Zanchetti A . Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens 2004; 18: 891–896.
Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. J Hypertens 2002; 20: 405–412.
Ogata C, Horio T, Kamide K, Takiuchi S, Kawano Y . Association between left ventricular diastolic dysfunction and renal haemodynamic change in patients with treated hypertension. Hypertens Res 2003; 26: 971–978.
Cuspidi C, Valerio C, Meani S, Esposito A, Negri F, Zanchetti A et al. Prevalence and correlates of multiple organ damage in a never treated hypertensive population: role of ambulatory blood pressure. Blood Press Monit 2008; 13: 7–13.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cuspidi, C., Valerio, C., Negri, F. et al. Prevalence and correlates of multiple organ damage in referred treated hypertensives: data from the ETODH study. J Hum Hypertens 22, 801–803 (2008). https://doi.org/10.1038/jhh.2008.56
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2008.56
This article is cited by
-
Blood pressure control and its associated factors among patients with heart failure in Jordan
Journal of Human Hypertension (2023)
-
Cardiovascular risk stratification and antihypertensive therapy according to guidelines in the outpatient setting
Wiener Medizinische Wochenschrift (2011)
-
Hypertension treatment and control evolution from single risk and single organ to multirisks and multiorgans
Journal of Human Hypertension (2008)